Gooya Innovative Biotech Company is a knowledge-based enterprise established in 2007 in Baharestan Industrial Park, Alborz Province, under the brand name INOCLON. The company was founded with the aim of producing various types of animal cell culture media and other related biotechnology products on an industrial scale. It prides itself on being the first, most advanced, and largest industrial-scale manufacturer of cell culture media in the Middle East, serving the needs of the recombinant pharmaceutical industry in addition to meeting research demands within the country.

The company, in addition to holding GMP pharmaceutical standards and ISO 13485 and ISO 9001 quality management certifications, is committed to using the highest-quality raw materials sourced from reputable global manufacturers. The laboratory specialists regularly evaluate the raw materials and the company’s final products using the most advanced laboratory equipment to ensure compliance with the latest international standards.

With over a decade of experience in producing sterile products, Goya Bio-Innovation has been exclusively involved in pharmaceutical production since 2016, initially focusing on sterile ophthalmic products and nutritional supplements. With a mission to enhance quality of life through innovative health solutions, make the latest global pharmaceuticals available with the highest quality, achieve self-sufficiency in drug production, and create employment opportunities, the company plans to leverage its 10 years of experience and active presence in the national pharmaceutical industry to produce and introduce a wide range of pharmaceutical products to the domestic and regional markets.

The company is determined to expand and improve its production lines and product range in the near future by leveraging a dynamic and effective setup, utilizing state-of-the-art technology, scientific and efficient management, and a skilled and experienced workforce to continue its growth in the fields of biotechnology and pharmaceuticals.